PatLynk & Alliance PEP Santé: Expanding Patient Access and Driving Innovation
A powerful alliance putting patients at the heart of clinical research
Many people around the world are eager to take part in clinical trials but struggle to find studies that match their specific medical needs. A global survey, for example, showed that roughly 74.5 % of respondents were willing to join a trial, yet actual enrollment remains low because of obstacles such as limited awareness, complex eligibility criteria and logistical hurdles (Source: JAMA Network). At the same time, many trials lack diversity and broad patient involvement, which can undermine the effectiveness of new treatments for the wider population and leave countless individuals searching for innovative options and representation in research.
Recognising these challenges, PatLynk and Alliance PEP Santé have teamed up to put patients front and centre. By combining PatLynk’s AI-powered smart-matching platform with Alliance PEP Santé’s deep expertise in connecting patients and caregivers with healthcare professionals, the partnership is re-imagining access to clinical research, empowering both patients and health-care teams, and opening new paths to medical innovation.
________________________________________
Alliance PEP Santé: A community of health actors and patients—true partners
Alliance PEP Santé is a nationwide association dedicated to improving healthcare practices through patient partnership and experience. Its guiding belief is simple: when patients are treated as genuine partners—when their lived experience and voices inform every stage and every field of the health system—we can collectively rebuild and improve that system.
By weaving the patient perspective into research and innovation, we make medicine more human, more connected and more relevant to real-world needs.
________________________________________
PatLynk: Making medical innovation accessible to everyone
PatLynk is a pioneering digital-health platform that connects patients with clinical trials tailored to their unique medical profiles. Powered by advanced, patient-centric AI, PatLynk streamlines the search for research opportunities so that every patient can take part in medical innovation.
________________________________________
Building a new vision of patient access
Imagine a world in which every patient—whatever their journey, language or home address—knows about every trial that could help them. Today, many studies are delayed or fail because too few people enrol, leaving promising treatments unexplored and patients without solutions. This isn’t just a recruitment challenge; it’s a missed opportunity to transform care.
By joining forces, PatLynk and Alliance PEP Santé are creating a seamless, patient-centered pathway that:
• Raises awareness – Through joint webinars, workshops and educational materials, we inform patients and healthcare professionals about the importance of clinical research and the opportunities that exist.
• Delivers personalised matching – PatLynk’s AI-driven platform connects patients to relevant studies based on their health data, preferences and location.
• Provides guidance – Alliance PEP Santé offers support and patient expertise, making the research journey simpler and less intimidating.
By aligning cutting-edge technology with lived experience, we are building a fairer, more efficient system in which taking part in research is no longer a privilege but a right. Our goal is to empower patients, support researchers and accelerate the development of better treatments for everyone.
________________________________________
Conclusion: Shaping a more inclusive future together
Invisible barriers should never prevent patients from accessing the care and innovation they deserve. The collaboration between PatLynk and Alliance PEP Santé is more than a partnership—it is a movement to ensure that every patient, whatever their condition or background, has a voice in the future of medicine.
PatLynk is committed to linking patients with trials that fit their needs, breaking down obstacles and promoting diversity in research. By working hand-in-hand with organisations like Alliance PEP Santé, we are making clinical trials more accessible, more inclusive and more meaningful for all.